Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients

Table 1

Case series.

	Number of cases
Total number of patients	110
Prostate cancer patients	55
Gleason score
6	19
7	25
8–10	8
Unknown	3
Pathological stage
pT2a	13
pT2b	1
pT2c	13
pT3a	16
pT3b	1
Unknown	11
Median PSA (range)	6.32 (3.1–118.4)
Median UCF-DNA integrity (range)	0.06 (0–2.56)
Patients with benign diseases	55
Benign prostatic disease	23
Benign kidney and bladder diseases	21
Others	11
Median PSA (range)	1.38 (0–14.00)
Median UCF-DNA integrity (range)	0.06 (0–3.41)

Patients without PSA and UCF-DNA integrity results were excluded; UCF: urine cell-free.